A randomized, controlled trial of the pan-PPAR agonist lanifibranor in NASH.

MLA

Francque S.M., et al. A Randomized, Controlled Trial of the Pan-PPAR Agonist Lanifibranor in NASH. 2021. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsoai&AN=edsoai.on1305118325&authtype=sso&custid=ns315887.

APA

Francque S.M., Bedossa P., Ratziu V., Anstee Q.M., Bugianesi E., Sanyal A.J., Loomba R., Harrison S.A., Balabanska R., Mateva L., Lanthier N., Alkhouri N., Moreno C., Schattenberg J.M., Stefanova-Petrova D., Vonghia L., Rouzier R., Guillaume M., Hodge A., … Abdelmalek M.F. (2021). A randomized, controlled trial of the pan-PPAR agonist lanifibranor in NASH.

Chicago

Francque S.M., Bedossa P., Ratziu V., Anstee Q.M., Bugianesi E., Sanyal A.J., Loomba R., et al. 2021. “A Randomized, Controlled Trial of the Pan-PPAR Agonist Lanifibranor in NASH.” http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsoai&AN=edsoai.on1305118325&authtype=sso&custid=ns315887.